Stomach Cancer Prevention and Early Detection Act

This legislation, known as the Stomach Cancer Prevention and Early Detection Act , mandates a comprehensive review by the Director of the National Cancer Institute (NCI) into the current landscape of stomach cancer in the United States. This review will cover various aspects, including the incidence of the disease, associated risk factors, the optimal age range for testing and treating Helicobacter pylori (H. pylori) infection, and the availability and effectiveness of current screening methods, particularly for high-risk populations. The NCI's review will also assess public and healthcare provider awareness regarding stomach cancer risk factors, symptoms, prevention, and treatment options, as well as existing federal awareness efforts. Within 18 months of enactment, the NCI Director must submit a report to Congress detailing these findings. This report must also include recommendations for establishing a clear definition of high-risk populations, informing stakeholders about identifying high-risk individuals and effective detection methods, establishing routine screening guidelines, and improving research, prevention, and early diagnosis strategies. In parallel, the bill requires the Secretary of Defense, in coordination with the NCI and the Centers for Disease Control and Prevention, to conduct a study on stomach cancer among active duty and former members of the Armed Forces. This study will examine incidence, prevalence, and mortality rates, identify service-related or deployment-related risk factors such as exposure to burn pits or contaminated water, and analyze disparities in outcomes based on demographics or deployment history. The Department of Defense study will also assess the availability and use of stomach cancer services within military and Department of Veterans Affairs health systems, seeking opportunities to improve prevention and early detection. A report on these findings, including policy and programmatic recommendations to reduce stomach cancer incidence and mortality among military populations, and strategies for integrating awareness, screening, and treatment protocols into military and VA health systems, is due to Congress within 18 months.